Navigation Links
Hypertension develops early, silently, in African-American men
Date:11/16/2008

risk factor for heart disease, stroke, congestive heart failure, and kidney disease. In 2002, hypertension was listed as a primary or contributing cause of death for 277,000 Americans.

The University of Illinois researchers hypothesized that the blood vessels of the black men would show greater dysfunction than the white men, even though both groups were young and equally healthy and fit. The vascular damage they looked for included stiffening and thickening of the blood vessels. These conditions result in pulsatile (not smooth) blood flow (and at higher pressure) to organs. The pressure can damage the organs over time.

Both groups healthy

The study included 55 young men, 30 white and 25 African-American. Most were university seniors. The average age was 23. There were no differences between the groups on a variety of measures, including heart rate, cardiorespiratory fitness, body mass index, body fat, blood lipids and glucose levels.

The researchers measured vascular function in a variety of ways, including:

  • aortic blood pressure and stiffness
  • brachial blood pressure
  • carotid artery blood pressure
  • carotid artery thickness and stiffness

They found the African-American men had similar brachial blood pressure, compared to the white men, but they had significantly higher:

  • Central blood pressure, a measure of the pressure found in the artery, near the heart. The researchers used an instrument that takes blood pressure at the wrist and then calculates the central blood pressure.
  • Carotid artery pressure. The carotid artery runs through the neck.

The African-American men, unlike the white men, also showed signs of early vascular damage that could lead to hypertension. For example, they had:

  • Thicker carotid arteries, a sign of vascular damage that is usually found in older individuals and associated with atherosclerosis.
  • Stiffer a
    '/>"/>

Contact: Christine Guilfoy
cguilfoy@the-aps.org
301-634-7253
American Physiological Society
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Understanding hypertension in African Americans proves elusive
2. Ultra-low-dose aspirin might decrease bleeding severity in portal hypertension
3. Researchers discovery may lead to hypertension treatment
4. Rare genetic mutations protect against hypertension
5. Hypertension treatment effective in reversing vascular damage
6. A single mechanism for hypertension, insulin resistance and immune suppression
7. Blood pressure response to daily stress provides clues for better hypertension treatment
8. Hypertension disparity linked to environment
9. Severe gestational hypertension may protect against testicular cancer
10. How schizophrenia develops: Major clues discovered
11. MIT develops tractor beam for cells, more

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... , DURHAM, N.H. University of New Hampshire mi...taling $498,115 to advance understanding of the ac...tential to enrich nutrient-poor and contaminated s...ture (USDA) awarded Tisa, a professor of molecular...plore the symbiotic relationship between the bacte...
(Date:11/23/2009)... , , University of Southern California biomedical...s to develop a new tool to help clinicians disting...ry from chronic problems manageable with drugs and...catheters inserted into the arteries feeding the h... ("lumen") of these blood vessels, often revealing...
(Date:11/23/2009)... , Amphibians like frogs and toads have existed f...rs didn,t, but a new aquatic fungus is threatening...icle in the November issue of Microbiology Today ... (Bd), was found to be associated with waves of a...eastern Australia in the 1990,s. Bd infects over 3...
Breaking Biology News(10 mins):UNH prof. receives nearly $500,000 to research environmentally significant plants 2Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2H D Smith Promotes Leadership to Fill Two Senior Roles 51210 1H D Smith Promotes Leadership to Fill Two Senior Roles 51210 2ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 1ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 2ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 3ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 4ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 5Study identifies potential fix for damaged knees 51203 1Study identifies potential fix for damaged knees 51203 2Study identifies potential fix for damaged knees 51203 3
...ngineers at MIT are developing a tiny sensor that ...dous gases, including toxic industrial chemicals a... current devices. , The researchers have taken th... spectrometry and shrunk them to fit in a device t... led by MIT Professor Akintunde Ibitayo Akinwande,...
...tes Xie Lab has published findings that begin to c...g stem cells within their cellular microenvironme...ays issue of Cell Stem Cell. , The Xie Lab demon...ovarian germline stem cells (GSCs), behaving like ...em cells for a position in the niche. They do so b...
... NY Cold Spring Harbor Laboratorys (CSHL) researc... by Joans Legacy: The Joan Scarangello Foundation ...nd CSHLs pioneering lung cancer research involving...e a trigger in non-small cell lung cancer, the lea..., The mutations, called epidermal growth factor r...
Other Biology News:MIT gas sensor is tiny, quick 2Cold Spring Harbor Laboratory's lung cancer research program awarded $100,000 grant 2
(Date:11/24/2009)...November24/PRNewswire-FirstCall/--deCODE,genetics,...noticefrom,theNasdaqStockMarketthattradinginthecom...09andaForm25-NSEwillbefiledwiththe,SecuritiesandEx...k,fromlistingonNasdaq,unlessthecompanyfilesanappea...hasfiledsuchanappeal,which,willstaythesuspensionan...
(Date:11/24/2009)...Newswire-Asia/--NODPharmaceuticalsInc.announced,th...entapplicationfor,itsnano-particleoraldeliveryorNO...tapproachtoincorporatepeptidesor,proteinsintobio-a...therwiseadministeredasinjections.NODtechnologyisap...ulardrugssuchasinsulin,interferon,growthhormone,e...
(Date:11/24/2009)...The FBI recently approved the Promega PowerPlex 16...n or generating DNA records for the National DNA I...I USA (PRWEB) -- The FBI recently approved the Pro...ratories participating in, or generating DNA recor... currently contains more than seven million profil...
(Date:11/24/2009)...09/PRNewswire-FirstCall/--ArenaPharmaceuticals,Inc...heduledtopresentatthePiperJaffray21stAnnualHealthC...e(8:30a.m.PacificTime)attheNewYorkPalaceHotelinNew...iveOfficer,isscheduledtoprovideanoverviewofthecomp...grams. ,, Aliveaudiowebcastofthepresentationwil...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...ransfer Paves the Way for the Phase III Clinical D...00 in Developing Countries, LEUVEN, Belgium, Sept..., a biotechnology company focused on vascular dise...the technology transfer to Bharat,Biotech Internat...re of,THR-100, a novel variant of Recombinant Stap...
...EIJING, Sept. 3 /Xinhua-PRNewswire-FirstCall/ -- C...asdaq: CMED ), a leading China-based,medical devi... advanced in-,vitro diagnostic products and high i... today announced that it will participate in Credi...a Day. Location: Shenzhen, China Date:...
...ARIS, September 2 Sanofi-aventis announced,today ...IMI 25 and STEEPLE,studies confirm clear net clini...vation myocardial infarction (STEMI) for Lovenox(R...IMI 25 and STEEPLE one year results were presented...f Cardiology (ESC) Congress in,Vienna, Austria. E...
Other Biology Technology:ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent 2ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent 3ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent 4New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome 2New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome 3New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome 4New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome 5
...icroarray Stabilizer is a is a bovine protein-free...product is an aqueous solution that contains non-t... saline), pH 6.6 - 7.2. This product contains a c...bromonitrodioxane as a preservative. StabilGuard ...
...unting medium designed for the preservation of flu...pecially recommended when using tracers containing...uoroBlue. It can also be used with conventional fl...amine (TMRITC) and Texas Red. Gel/Mount is a non-g...
RNAsin from BD Biosciences Pharmingen
...NK1 (phospho T183 + Y185) Immunogen Synthetic pe...sphorylated T183/Y185. Reactivity / Specificity ...sted in other species. Background Information MA...the ERK, JNK, and p38 kinases. The members are reg...
Biology Products: